Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging.

OBJECTIVE Several single-voxel proton magnetic resonance spectroscopy (1H-MRS) studies of patients with schizophrenia have found evidence of reductions of N-acetyl-aspartate (NAA) concentrations in the temporal lobes. Multislice proton magnetic resonance spectroscopy imaging (1H-MRSI) permits simultaneous acquisition and mapping of NAA, choline-containing compounds (CHO), and creatine/phosphocreatine (CRE) signal intensities from multiple whole brain slices consisting of 1.4-ml single-volume elements. We have used 1H-MRSI to assess the regional specificity of previously reported changes of metabolite signal intensities in schizophrenia. Hippocampal volume was also measured to test the relationship between 1H-MRSI findings and tissue volume in this region. METHOD Ratios of areas under the metabolite peaks of the proton spectra were determined (i.e., NAA/CRE, NAA/CHO, CHO/CRE) for multiple cortical and subcortical regions in 10 inpatients with schizophrenia. RESULTS Patients showed significant reductions of NAA/CRE and NAA/CHO bilaterally in the hippocampal region and in the dorsolateral prefrontal cortex. There were no significant changes in CHO/CRE or in NAA ratios in any other area sampled. No significant correlation was found between metabolite ratios in the hippocampal region and its volume. CONCLUSIONS NAA-relative signal intensity reductions in schizophrenia appear to be remarkably localized, involving primarily the hippocampal region and the dorsolateral prefrontal cortex, two regions implicated prominently in the pathophysiology of this disorder.

[1]  P. Renshaw,et al.  Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls , 1996, Schizophrenia Research.

[2]  M. Hallett,et al.  Proton magnetic resonance spectroscopic imaging in patients with cerebellar degeneration , 1996, Annals of neurology.

[3]  D. Jeste,et al.  Hippocampal pathologic findings in schizophrenia. A morphometric study. , 1989, Archives of general psychiatry.

[4]  Edith V. Sullivan,et al.  Volumetric MRI assessment of temporal lobe structures in schizophrenia , 1994, Biological Psychiatry.

[5]  P. Renshaw,et al.  Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. , 1995, The American journal of psychiatry.

[6]  F. Benes,et al.  Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. , 1986, Archives of general psychiatry.

[7]  J. Tsuruda,et al.  Partial volume effects in volume localized phased‐array proton spectroscopy of the temporal lobe , 1995, Journal of magnetic resonance imaging : JMRI.

[8]  Toshiro Fujimoto,et al.  Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report , 1995, Psychiatry Research: Neuroimaging.

[9]  Karl J. Friston,et al.  Abnormal frontotemporal interactions in patients with schizophrenia , 1995 .

[10]  H Merskey,et al.  Frontal, temporal, and striatal proton relaxation times in schizophrenic patients and normal comparison subjects. , 1992, The American journal of psychiatry.

[11]  P. Barker,et al.  AIDS dementia complex: evaluation with proton MR spectroscopic imaging. , 1995, Radiology.

[12]  Daniel R. Weinberger,et al.  Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground , 1995, Schizophrenia Research.

[13]  M Xue,et al.  Temporal lobe epilepsy: presurgical localization with proton chemical shift imaging. , 1994, Radiology.

[14]  G Scarlato,et al.  Central nervous system trans‐synaptic effects of acute axonal injury: a 1h magnetic resonance spectroscopy study , 1995, Magnetic resonance in medicine.

[15]  J. Frahm,et al.  Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. , 1993, Radiology.

[16]  G J Barker,et al.  Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia , 1995, Psychological Medicine.

[17]  J. Kleinman,et al.  Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. , 1995, Archives of general psychiatry.

[18]  B J Soher,et al.  Acute stroke: evaluation with serial proton MR spectroscopic imaging. , 1994, Radiology.

[19]  D. Weinberger,et al.  Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. , 1990, The New England journal of medicine.

[20]  J. Vion-Dury,et al.  Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy , 1995, The Lancet.

[21]  P. Goldman-Rakic,et al.  Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. , 1995, Archives of general psychiatry.

[22]  H. Moser,et al.  Multislice proton magnetic resonance spectroscopic imaging in X‐linked adrenoleukodystrophy , 1994, Annals of neurology.

[23]  B T Hyman,et al.  Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. , 1991, Archives of general psychiatry.

[24]  John P. Stack,et al.  1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: Clinical, neurodevelopmental, and cognitive correlates , 1994, Biological Psychiatry.

[25]  J. Ehrhardt,et al.  Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging. , 1994, JAMA.

[26]  D. Weinberger,et al.  From neuropathology to neurodevelopment , 1995, The Lancet.

[27]  A. Bizzi,et al.  Response of non-Hodgkin lymphoma to radiation therapy: early and long-term assessment with H-1 MR spectroscopic imaging. , 1995, Radiology.

[28]  G Tedeschi,et al.  Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging , 1995, Neurology.

[29]  B. Miller.  A review of chemical issues in 1H NMR spectroscopy: N‐acetyl‐l‐aspartate, creatine and choline , 1991, NMR in biomedicine.

[30]  D. Gadian,et al.  Magnetic resonance spectroscopy in temporal lobe epilepsy , 1994, Neurology.

[31]  Daniel R. Weinberger,et al.  Medial temporal lobe structures in schizophrenia: relationship of size to duration of illness , 1994, Schizophrenia Research.

[32]  S. Otsuki,et al.  The Influences of Insulin Hypoglycaemic Coma, Repeated Electroshocks, and Chlorpromazine or β-Phenylisopropylmethylamine Administration on the Free Amino Acids in the Brain , 1959 .

[33]  P. Matthews,et al.  Chemical pathology of acute demyelinating lesions and its correlation with disability , 1995, Annals of neurology.

[34]  M. A. Samphilipo,et al.  Quantitative proton spectroscopy of canine brain: in Vivo and in Vitro correlations , 1994, Magnetic resonance in medicine.

[35]  R. Buchanan,et al.  Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. , 1992, Archives of general psychiatry.

[36]  G J Barker,et al.  The proton NMR spectrum in acute EAE: The significance of the change in the Cho:Cr ratio , 1993, Magnetic resonance in medicine.

[37]  Jullie W Pan,et al.  Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T , 1995, Annals of neurology.

[38]  D. Gadian,et al.  H magnetic resonance spectroscopy in the investigation of intractable epilepsy , 1994, Acta neurologica Scandinavica. Supplementum.

[39]  Jullie W Pan,et al.  Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1T , 1994, Magnetic resonance in medicine.

[40]  J H Duyn,et al.  Multisection proton MR spectroscopic imaging of the brain. , 1993, Radiology.

[41]  P Schmalbrock,et al.  Proton Magnetic Resonance Spectroscopy (1H MRS) of the Hippocampal Formation in Schizophrenia: A Pilot Study , 1994, British Journal of Psychiatry.